Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...

Practitioners and investors please take note. Drugs taken orally to treat common bladder conditions, notably antibiotics and...

About UroPharma UroPharma has patented and developed the world’s first licensed ‘direct to bladder’ drug delivery system, that will be in...

Professor Glickman brought our attention to the following article which is very relevant to our R&D efforts and makes for interesting...

Development of dtb-Instilla Device is supported by the New Anglia Local Enterprise Partnership - Growth Through Innovation Fund This is...

Developing innovative drug delivery combinations for improved treatments of functional bladder disorders and urinary tract infections....

From 1st January 2021 all medical devices placed on the market must be registered by their manufacturers with the MHRA as part of a...

Among more than 50,000 Canadians with MS, the rates of breast and colorectal cancers were not increased compared with people without MS....

Rollout of two-shot jab could begin as soon as December 7 The UK is poised to become the first western country to approve a Covid-19...

The impact of a new Covid vaccine will kick in significantly over summer and life should be back to normal by next winter, one of its...

Claiming equivalence with a device that is already CE marked can help medical device companies save time and money. But scandals with...

NICE has today (15 October 2020) issued draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for...

UKCA mark and Northern Ireland mark (UKNI) Manufacturers who are not supplying the EU/EEA markets might prefer the UK regulatory system...

A test, which uses patented technology to detect MCM5 in urine, could help urologists rule out bladder cancer in as little as two hours....

A programme supporting health care providers to create the conditions that will enable faster and more effective uptake of innovations...

More

Almost half of medtech companies expect to spend 5% or more of their annual revenue on the EU Medical Device Regulation, results of a...

The European Commission has adopted a third amendment to extend the scope of the State aid Temporary Framework adopted on 19 March 2020...

The scarcity of facemasks, particularly N95 respirators, combined with the lack of solid data to address the suitability of each mask...

As medicine shifts away from measuring success of treatments purely on increased survival chance, an increase in patient’s quality of...